During the past decade, Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz" #1 collaborator was "CoLucid Pharmaceuticals" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz" are "Alzheimer's Disease" (3 trials), "Alzheimer Disease" (2 trials), "Relapsing Multiple Sclerosis" (2 trials), "Migraine" (1 trials) and "Migraine Disorders" (1 trials). Many other conditions were trialed in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz" in a lesser frequency.

Most popular intervention types in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ocrelizumab" (4 trials), "Gantenerumab" (3 trials), "Fenebrutinib" (2 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".